Renal Pelvis Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Pelvis Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urotheli…
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer [Phase 2]
This Phase 2 trial update tests atezolizumab with or without eribulin mesylate in patients with recurrent locally advanced or metastatic uro…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors [Phase 1]
Phase 1 trial evaluating cabozantinib S-malate with nivolumab, with or without ipilimumab, in patients with metastatic genitourinary tumors;…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer [Phase 2]
Phase 2 clinical trial evaluating nephron-sparing treatment with tislelizumab plus nab-paclitaxel for renal pelvis urothelial carcinoma; cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Genotype-Phenotype Urothelial Cancer Registry
A genotype-phenotype urothelial cancer registry sponsored by Memorial Sloan Kettering Cancer Center; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours [Phase 4]
A Phase 4 trial evaluated the effects of dexmedetomidine during radiofrequency ablation of abdominal tumors. The study involving cancers of …